© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > CC-90009
<< Back to February
CRBN-based GSPT1 molecular glue degrader
intravenous agent in Ph. I for AML + MDS
from phenotypic screen of CRBN mod library
J. Med. Chem., Feb. 16, 2021
Celgene/Bristol Myers Squibb, San Diego, CA
1. The Bristol Myers Squibb (BMS)/Celgene GSPT1 degrader (CC-90009) is a CRBN-based molecular glue (CELMoD). It is a clinical candidate in Ph. I for AML and MDS, and in…
Unlock this content with a Premium membership to read it now.